Targeting NBL1/PI3K/AKT axis to enhance the chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma
International Immunopharmacology · 2026-07 · 180 · 116665
DOI: 10.1016/j.intimp.2026.116665 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-07. Verfasst von Bing Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong 250021, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Cell Cycle Proteins. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Wu Jieping Medical Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.
- Tumor Research and Therapy Center, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.
- Tumor Research and Therapy Center, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, China.
- Tumor Research and Therapy Center, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong 250021, China; Shandong University, Shandong Provincial Hospital, Jinan, Shandong 250021,…
- Department of Oncology, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong 250021, China. Electronic address: fengbincn@126.com.
Förderung
- Wu Jieping Medical Foundation
Zitieren
APA
Wang, B., Zeng, R., Lei, L., Yang, Z., & Feng, B. (2026). Targeting NBL1/PI3K/AKT axis to enhance the chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma. International Immunopharmacology, 180, 116665. https://doi.org/10.1016/j.intimp.2026.116665
Vancouver
Wang B, Zeng R, Lei L, Yang Z, Feng B. Targeting NBL1/PI3K/AKT axis to enhance the chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma. International Immunopharmacology. 2026;180:116665. doi:10.1016/j.intimp.2026.116665
BibTeX
@article{Wang2026,
author = {Wang, Bing and Zeng, Renya and Lei, Lingli and Yang, Zhe and Feng, Bin},
title = {Targeting NBL1/PI3K/AKT axis to enhance the chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma},
journal = {International Immunopharmacology},
year = {2026},
volume = {180},
pages = {116665},
doi = {10.1016/j.intimp.2026.116665}
}
EUVIMED